Kolexia
Petrirena Hernandez Gregorio
Neurologie
Hôpital La Timone
Marseille, France
45 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Gliome Glioblastome Tumeurs du cerveau Lymphomes Métastase tumorale Récidive tumorale locale Hémorragie Accident vasculaire cérébral Accident vasculaire cérébral ischémique

Industries

BMS
1 collaboration(s)
Dernière en 2020
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

StrateGlio: Phase III Randomised Trial Evaluating Treatment Intensification With Temozolomide in Adults With a Glioblastoma
Essai Clinique (Centre Oscar-Lambret)   08 février 2024
Prognostic value of Beta 2-Microglobulinin in cerebrospinal fluid in primary central nervous system lymphoma.
Journal of the neurological sciences   18 décembre 2023
Primary central nervous system lymphoma with initial spinal cord involvement (PCNSL-SC) is a rare entity: 4 case reports and review of literature
Revue neurologique   26 octobre 2023
546P Early urinary potassium level is predictive of delayed methotrexate (MTX) elimination in patients with primary central nervous system lymphoma (PCNSL)
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Radio-chemotherapy feasibility for biopsy-only unresectable wild-type glioblastomas (BO-GBM).
Neuro-oncology practice   30 mai 2023
Le méningiome est une tumeur bénigne… sauf quand il est malin
Journées de Neurologie de Langue Française 2023   01 avril 2023
Prognostic value of circulating lymphocyte subsets in primary central nervous system lymphoma.
Journal of neuro-oncology   28 juin 2022
Urinary potassium and association with methotrexate (MTX) elimination delay in patients with primary central nervous system lymphoma (PCNSL).
2022 ASCO Annual Meeting I   02 juin 2022
Adult H3K27M mutated thalamic glioma patients display a better prognosis than unmutated patients.
Journal of neuro-oncology   07 janvier 2022
QOLP-09. AUTONOMY DURATION AS ANALYZED BY KPS ≥ 70 CUMULATIVE TIME IN PATIENTS WITH BIOPSY-ONLY GLIOBLASTOMA (BO-GBM). A SUB-ANALYSIS OF THE TIMONE COHORT
Abstracts from the 2021 Society for Neuro-Oncology’s 26th Annual Scientific Meeting and Education Day   12 novembre 2021